drugset / Trial / NCT04428268
Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia
RandomizedParallel-groupDouble-blindTreatment
Summary
Study design Phase 2, double blinded, single-center, 1:1 randomized clinical trial of Chloroquine vs Chloroquine/losartan for the treatment of SARS-CoV-2 pneumonia in non-critically ill subjects
Timeline
- Start
- 2020-03-10
- Primary completion
- 2020-06-10
- Completion
- 2021-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 25 mg | Oral |
| Background | Chloroquine | Small molecule | 450 mg | Oral |